文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

医院获得性肺炎微生物诊断的有创与非有创方法

Invasive and non-invasive diagnostic approaches for microbiological diagnosis of hospital-acquired pneumonia.
PubMed 文献 · Crit Care · 2019-02-18
一句话结论在ICU非机械通气的医院获得性肺炎患者中,有创采样微生物诊断率高于无创采样(56% vs 39%,p=0.018),痰培养在未插管患者中贡献了三分之一的微生物诊断。

该研究在西班牙巴塞罗那一家教学医院的6个ICU中分析了200例医院获得性肺炎(HAP)患者,比较无创(痰、气管内吸引)与有创(纤维支气管镜吸引、支气管肺泡灌洗)呼吸道采样方法的微生物诊断效能。结果显示,93%的患者至少采用一种呼吸道采样方法,40%采用两种或以上;50%的患者获得微生物诊断,其中70%仅由一种方法确定。有创组微生物诊断率显著高于无创组(56% vs 39%,p=0.018)。获得微生物诊断的患者更常调整经验性抗生素方案,主要为降阶梯治疗。作者认为对重症非机械通气HAP患者可采取综合诊断策略。

要点

  • 在6个ICU的200例HAP患者中,有创采样(纤维支气管镜吸引、支气管肺泡灌洗)微生物诊断率为56%,无创采样(痰、气管内吸引)为39%,差异有统计学意义(p=0.018)。
  • 93%的患者至少应用一种呼吸道采样方法,40%应用两种或以上;微生物诊断在50%的患者中实现,其中70%仅由一种方法确定。
  • 在未接受机械通气的患者中,78例(39%)接受了纤维支气管镜检查。
  • 痰采样在未随后插管的HAP患者中确定了三分之一的微生物诊断。
  • 获得微生物诊断的患者更常出现经验性抗生素方案调整,主要为降阶梯治疗。

适用人群与场景

  • 来自西班牙巴塞罗那一家教学医院6个ICU的200例医院获得性肺炎(HAP)患者,包括未接受机械通气的患者。

研究设计与关键结果

  • 研究类型为在6个ICU开展的观察性分析,纳入200例HAP患者;中位应用3种诊断方法(范围2–4种)。
  • 至少一种呼吸道采样方法应用于93%的患者,两种或以上应用于40%。
  • 99例(50%)患者获得微生物诊断,其中69例(70%)仅由一种方法确定:纤维支气管镜吸引42%、气管内吸引23%、痰15%、支气管肺泡灌洗9%、血培养7%、尿抗原4%。
  • 78例(39%)患者在未接受机械通气时接受了纤维支气管镜检查。
  • 有创组微生物诊断率56% vs 无创组39%(p=0.018)。
  • 获得微生物诊断的患者更常出现经验性抗生素方案调整,主要为降阶梯治疗。

证据类型、等级与局限

  • 证据类型:单中心观察性分析(西班牙巴塞罗那一家教学医院6个ICU)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对重症非机械通气的HAP患者可采取综合方法进行微生物诊断。
  • 作者指出,有创方法与更高的微生物诊断率相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Data on the methods used for microbiological diagnosis of hospital-acquired pneumonia (HAP) are mainly extrapolated from ventilator-associated pneumonia. HAP poses additional challenges for respiratory sampling, and the utility of sputum or distal sampling in HAP has not been comprehensively evaluated, particularly in HAP admitted to the ICU.

METHODS: We analyzed 200 patients with HAP from six ICUs in a teaching hospital in Barcelona, Spain. The respiratory sampling methods used were divided into non-invasive [sputum and endotracheal aspirate (EAT)] and invasive [fiberoptic-bronchoscopy aspirate (FBAS), and bronchoalveolar lavage (BAL)].

RESULTS: A median of three diagnostic methods were applied [range 2-4]. At least one respiratory sampling method was applied in 93% of patients, and two or more were applied in 40%. Microbiological diagnosis was achieved in 99 (50%) patients, 69 (70%) by only one method (42% FBAS, 23% EAT, 15% sputum, 9% BAL, 7% blood culture, and 4% urinary antigen). Seventy-eight (39%) patients underwent a fiberoptic-bronchoscopy when not receiving mechanical ventilation. Higher rates of microbiological diagnosis were observed in the invasive group (56 vs. 39%, p = 0.018). Patients with microbiological diagnosis more frequently presented changes in their empirical antibiotic scheme, mainly de-escalation.

CONCLUSIONS: A comprehensive approach might be undertaken for microbiological diagnosis in critically ill nonventilated HAP. Sputum sampling determined one third of microbiological diagnosis in HAP patients who were not subsequently intubated. Invasive methods were associated with higher rates of microbiological diagnosis.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Ranzani OT, Senussi T, Idone F, et al. Invasive and non-invasive diagnostic approaches for microbiological diagnosis of hospital-acquired pneumonia. Crit Care. 2019. PMID: 30777114. doi:10.1186/s13054-019-2348-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。